BONEX Bonesupport Holding AB (publ)

STO · SE · Healthcare · Medical Instruments & Supplies · bonesupport.com

227.80SEK+2.34%Mkt Cap: 1.39B $P/E: 69.35Today

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally. The company offers CERAMENT Bone Void…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc. - Common Stock

$140.43BUSDP/E 44.8

EssilorLuxottica Societe anonyme

$71.20BUSDP/E 26.7

BDX

Becton, Dickinson and Company Common Stock

$48.16BUSDP/E 30.5

MDLN

Medline Inc. - Class A common stock

$47.91BUSDP/E 44.5

RMD

ResMed Inc. Common Stock

Alcon Inc. Ordinary Shares

$30.82BUSDP/E 48.7

WST

West Pharmaceutical Services, Inc. Common Stock

$25.69BUSDP/E 46.8

DIM

Sartorius Stedim Biotech

$22.02BUSDP/E 69.2

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.20BUSDP/E 71.6

SOLV

Solventum Corporation Common Stock

$14.95BUSDP/E 10.7

BAX

Baxter International Inc. Common Stock

$12.14BUSD

COO

The Cooper Companies, Inc. - Common Stock

$10.82BUSDP/E 19.6

AVTR

Avantor, Inc. Common Stock

$10.38BUSD

COO

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

RGEN

Repligen Corporation - Common Stock

$10.25BUSDP/E 248.9

ALGN

Align Technology, Inc. - Common Stock

$10.21BUSDP/E 25.0

ATR

AptarGroup, Inc. Common Stock

$7.62BUSDP/E 21.6

Key Statistics

Company

Market Cap1.39B USD

Enterprise Value1.36B USD

Revenue (TTM)123.05M USD

Gross Profit104.01M USD

Net Income (TTM)13.60M USD

Revenue/Share19.50 SEK

Last Price227.80 SEK

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees171

CountrySE

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)69.35

P/E (Forward)50.94

PEG—

EV/EBITDA45.70

EV/Revenue11.07

P/S11.29

P/B15.44

EPS (TTM)3.21

EPS (Forward)4.37

52W Range

165.0044% of range306.80

52W High306.80 SEK

52W Low165.00 SEK

Profitability

Gross Margin92.57%

Oper. Margin23.91%

EBITDA Margin24.22%

Profit Margin12.10%

ROE16.39%

ROA13.72%

Growth

Revenue Growth25.10%

Earnings Growth55.70%

Cash Flow & Leverage

Operating CF21.17M USD

CapEx (TTM)496.91K USD

FCF Margin11.41%

FCF Yield1.01%

Net Debt-40.57M USD

Net Debt/EBITDA-1.36

Balance Sheet

Debt/Equity0.01

Current Ratio5.44

Quick Ratio3.93

Book Value/Sh14.42 SEK

Cash/Share6.59 SEK

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 SEK

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.0 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)356.58 SEK

Upside (mean)+56.5%

Target Range275.00 SEK – 416.00 SEK

275.00+56.5% to mean416.00

# Analysts6

Ownership

Shares Out.65.25M

Float58.85M

Insiders8.93%

Institutions57.60%

Technical

SMA 50222.27 (+2.5%)

SMA 200212.65 (+7.1%)

Beta0.48

S&P 52W Chg14.58%

Avg Vol (30d)324.42K

Avg Vol (10d)337.59K

Technical Indicators

RSI (14)50.8

MACD0.6124

MACD Signal-0.3734

MACD Hist.+0.9858

BB Upper232.99 SEK

BB Middle220.77 SEK

BB Lower208.55 SEK

BB Width11.07%

ATR (14)8.975 SEK

Vol Ratio (20d)0.68x